Literature DB >> 10373529

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit.

N Sizemore1, S Leung, G R Stark.   

Abstract

The work of Reddy et al. (S. A. Reddy, J. A. Huang, and W. S. Liao, J. Biol. Chem. 272:29167-29173, 1997) reveals that phosphatidylinositol 3-kinase (PI3K) plays a role in transducing a signal from the occupied interleukin-1 (IL-1) receptor to nuclear factor kappaB (NF-kappaB), but the underlying mechanism remains to be determined. We have found that IL-1 stimulates interaction of the IL-1 receptor accessory protein with the p85 regulatory subunit of PI3K, leading to the activation of the p110 catalytic subunit. Specific PI3K inhibitors strongly inhibit both PI3K activation and NF-kappaB-dependent gene expression but have no effect on the IL-1-stimulated degradation of IkappaBalpha, the nuclear translocation of NF-kappaB, or the ability of NF-kappaB to bind to DNA. In contrast, PI3K inhibitors block the IL-1-stimulated phosphorylation of NF-kappaB itself, especially the p65/RelA subunit. Furthermore, by using a fusion protein containing the p65/RelA transactivation domain, we found that overexpression of the p110 catalytic subunit of PI3K induces p65/RelA-mediated transactivation and that the specific PI3K inhibitor LY294,002 represses this process. Additionally, the expression of a constitutively activated form of either p110 or the PI3K-activated protein kinase Akt also induces p65/RelA-mediated transactivation. Therefore, IL-1 stimulates the PI3K-dependent phosphorylation and transactivation of NF-kappaB, a process quite distinct from the liberation of NF-kappaB from its cytoplasmic inhibitor IkappaB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373529      PMCID: PMC84278          DOI: 10.1128/MCB.19.7.4798

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

Review 2.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

3.  Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.

Authors:  J Huang; X Gao; S Li; Z Cao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase.

Authors:  K Reif; B M Burgering; D A Cantrell
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism.

Authors:  H Zhong; H SuYang; H Erdjument-Bromage; P Tempst; S Ghosh
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

6.  Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit.

Authors:  T A Bird; K Schooley; S K Dower; H Hagen; G D Virca
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

7.  p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

Authors:  W Vanden Berghe; S Plaisance; E Boone; K De Bosscher; M L Schmitz; W Fiers; G Haegeman
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

8.  IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway.

Authors:  M Bergmann; L Hart; M Lindsay; P J Barnes; R Newton
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

9.  Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation.

Authors:  S A Reddy; J H Huang; W S Liao
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

10.  CREB-binding protein/p300 are transcriptional coactivators of p65.

Authors:  M E Gerritsen; A J Williams; A S Neish; S Moore; Y Shi; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  156 in total

1.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

3.  ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.

Authors:  J L Smith; A E Schaffner; J K Hofmeister; M Hartman; G Wei; D Forsthoefel; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Mutant human cells with constitutive activation of NF-kappaB.

Authors:  Swati S Sathe; Nywana Sizemore; Xiaoxia Li; Kalpa Vithalani; Mairead Commane; Shannon M Swiatkowski; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

Review 5.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

6.  Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.

Authors:  Fenfen Xiang; Zhenhua Ni; Yueping Zhan; Qianqian Kong; Jian Xu; Jiemin Jiang; Rong Wu; Xiangdong Kang
Journal:  Tumour Biol       Date:  2015-11-23

7.  Using the variability of linkage disequilibrium between subpopulations to infer sweeps and epistatic selection in a diverse panel of chickens.

Authors:  T M Beissinger; M Gholami; M Erbe; S Weigend; A Weigend; N de Leon; D Gianola; H Simianer
Journal:  Heredity (Edinb)       Date:  2015-09-09       Impact factor: 3.821

8.  Regulation of CX3CL1 Expression in Human First-Trimester Decidual Cells: Implications for Preeclampsia.

Authors:  S Joseph Huang; Chie-Pein Chen; Lynn Buchwalder; Ya-Chun Yu; Longzhu Piao; Chun-Yen Huang; Frederick Schatz; Charles J Lockwood
Journal:  Reprod Sci       Date:  2019-01-03       Impact factor: 3.060

9.  Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity.

Authors:  Debra L Laskin; Ladan Fakhrzadeh; Diane E Heck; Donald Gerecke; Jeffrey D Laskin
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3,3'-diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein.

Authors:  Yabing Chen; Jianmin Xu; Nirag Jhala; Pritish Pawar; Zeng B Zhu; Liping Ma; Chang-Hyun Byon; Jay M McDonald
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.